9086:HK:HK-ChinaAMC NASDAQ 100 ETF (USD)

ETF | Others |

Last Closing

USD 5.095

Change

+0.05 (+0.89)%

Market Cap

N/A

Volume

600.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

+0.20 (+0.82%)

USD 159.33B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

+0.60 (+0.66%)

USD 30.56B
2801:HK iShares Core MSCI China ETF

+0.34 (+1.37%)

USD 22.44B
2823:HK iShares FTSE A50 China

-0.05 (-0.35%)

USD 17.65B
83188:HK ChinaAMC CSI 300 Index ETF

-0.26 (-0.62%)

USD 13.48B
9067:HK iShares Hang Seng TECH ETF

N/A

USD 9.22B
3067:HK iShares Hang Seng TECH ETF

-0.03 (-0.24%)

USD 9.22B
82822:HK CSOP FTSE China A50

-0.02 (-0.16%)

USD 8.59B
9010:HK iShares Core MSCI AC Asia ex J..

+0.07 (+0.89%)

USD 3.03B

ETFs Containing 9086:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -7.70% 27% F 28% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.70% 27% F 28% F
Trailing 12 Months  
Capital Gain 9.24% 60% D- 61% D-
Dividend Return 0.86% 6% D- 5% F
Total Return 10.10% 59% D- 59% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 20.24% 87% B+ 78% C+
Dividend Return 21.12% 86% B+ 76% C+
Total Return 0.88% 29% F 20% F
Risk Return Profile  
Volatility (Standard Deviation) 18.58% 56% F 78% C+
Risk Adjusted Return 113.69% 99% N/A 99% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.